Literature DB >> 25724805

Chronic inflammatory demyelinating polyneuropathy mimicking an acute painful diabetic neuropathy.

Antonietta Topa1, Raffaele Dubbioso, Rosa Iodice, Lucio Santoro, Fiore Manganelli.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25724805     DOI: 10.1007/s10072-015-2122-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  5 in total

1.  European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision.

Authors:  P Y K Van den Bergh; R D M Hadden; P Bouche; D R Cornblath; A Hahn; I Illa; C L Koski; J-M Léger; E Nobile-Orazio; J Pollard; C Sommer; P A van Doorn; I N van Schaik
Journal:  Eur J Neurol       Date:  2010-03       Impact factor: 6.089

2.  The natural history of acute painful neuropathy in diabetes mellitus.

Authors:  A G Archer; P J Watkins; P K Thomas; A K Sharma; J Payan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-06       Impact factor: 10.154

3.  Acute painful diabetic neuropathy following severe weight loss.

Authors:  F Castellanos; J Mascias; J A Zabala; C Ricart; A Cabello; A Garcia-Merino
Journal:  Muscle Nerve       Date:  1996-04       Impact factor: 3.217

4.  "Chronic sensory demyelinating neuropathy": chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy.

Authors:  S J Oh; J L Joy; R Kuruoglu
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

5.  Chronic inflammatory demyelinating polyneuropathy in diabetics: motor conductions are important in the differential diagnosis with diabetic polyneuropathy.

Authors:  A Uncini; M V De Angelis; A Di Muzio; C Callegarini; G Ciucci; G Antonini; A Lugaresi; D Gambi
Journal:  Clin Neurophysiol       Date:  1999-04       Impact factor: 3.708

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.